Early research (Phase 1)Ended earlyNCT02808052
What this trial is testing
Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency
Who this might be right for
Renal Insufficiency, AcuteRenal Insufficiency, ChronicHealthy Subjects
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 9